Drug recall · February 22, 2023
Abelcet recall
Why: Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exelead, Inc., Indianapolis, IN 46268; Distributed by Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 57665-101-41
- Lots / codes
Lot#: 1203A, Exp. 5/11/2024
- Quantity
- 31,879 vials
- Company
- Leadiant Biosciences, Inc., Gaithersburg, MD
- Distribution
- Nationwide USA
- Initiated
- February 3, 2023 · Voluntary: Firm initiated
- Classified
- February 15, 2023
- Reported
- February 22, 2023
- Ended
- September 30, 2024
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amphotericin B
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.